Martin Shkreli Was Apparently Live Streaming When FBI Agents Called
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Shkreli, Greebel plead 'not guilty' in securities fraud case - Bloomberg
December 17, 2015 3:22 PM ESTMartin Shkreli and Evan Greebel plead 'not guilty' in securities fraud case, according to Bloomberg. Greebel was charged alongside Shkreli.
... MoreStreetinsider.com's Hot Lunchtime Reads 12/17: (MU) (KBIO) (AMZN)
December 17, 2015 12:20 PM ESTThe following is a list of notable articles to help get you through the lunch hour:SEC Charges Martin Shkreli with Fraud -> Read this!
Morgan Stanley Sees Limited Downside in Micron (MU) and Upgrades Stock to Overweight -> Read this!
Forget FANG, Look at BAGEL in 2016 -> Read this!
... MoreMartin Shkreli 'essentially ran his companies like a ponzi scheme' - US Attorney
December 17, 2015 12:13 PM ESTMartin Shkreli "essentially ran his companies like a ponzi scheme" - US Attorney
... MoreSEC Charges Martin Shkreli with Fraud
December 17, 2015 12:06 PM EST(Updated - December 17, 2015 12:07 PM EST)
The Securities and Exchange Commission today charged Martin Shkreli, former CEO of pharmaceutical company Retrophin, with committing fraud during a five-year period when he also was working as a hedge fund manager.
The SEC alleges that Martin Shkreli misappropriated money from two hedge funds he founded and made material misrepresentations to investors among other widespread misconduct. The SEC also charged Retrophins former outside counsel and corporate secretary Evan Greebel with aiding and abetting certain aspects of Shkrelis alleged fraud.
In a parallel action, the U.S. Attorneys Office for the... More
More Shkreli Arrest Photos Surface (KBIO)
December 17, 2015 11:43 AM ESTMore images have been released of the arrest of Martin Shkreli.
Shkreli is the CEO of Turing Pharma and... More
Photo of Martin Shkreli Being Arrested by FBI Agents
December 17, 2015 11:25 AM ESTReuters photo of KaloBios Pharma (NASDAQ: KBIO) CEO, Martin Shkreli, getting arrested this morning in New York.
... MoreShkreli Indictment Document Posted (KBIO)
December 17, 2015 11:00 AM ESTEmbedded below is the indictment for Matin Shkreli, CEO of KaloBios (Nasdaq: KBIO) and Turing Pharma.
... MoreNASDAQ Affirms Trading Halt on KaloBios Pharma (KBIO)
December 17, 2015 10:42 AM ESTThe Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) at 06:48:07 Eastern Time for "additional information requested" from the company at a last price of $23.59.
Trading will remain halted until KaloBios... More
